5JCG
Structure of Human Peroxiredoxin 3 as three stacked rings
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | AUSTRALIAN SYNCHROTRON BEAMLINE MX2 |
Synchrotron site | Australian Synchrotron |
Beamline | MX2 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2015-04-24 |
Detector | ADSC QUANTUM 315 |
Wavelength(s) | 0.979 |
Spacegroup name | I 2 2 2 |
Unit cell lengths | 133.188, 168.730, 221.550 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 52.270 - 2.800 |
R-factor | 0.1849 |
Rwork | 0.183 |
R-free | 0.22880 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 1zye |
RMSD bond length | 0.009 |
RMSD bond angle | 1.378 |
Data reduction software | MOSFLM |
Data scaling software | Aimless |
Phasing software | PHASER |
Refinement software | REFMAC (5.8.0131) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 52.270 | 2.870 |
High resolution limit [Å] | 2.800 | 2.800 |
Rmerge | 0.176 | 0.713 |
Number of reflections | 61455 | |
<I/σ(I)> | 6.6 | |
Completeness [%] | 99.8 | 99.7 |
Redundancy | 12.7 | 12.3 |
CC(1/2) | 0.954 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 8.5 | 293 | 12.5% PEG1000, 12.5% PEG3350. 12.5% MPD, 0.02 M alcohol additives at pH 8.5 (Gorrec, 2009) |